Language selection

Search

Details for: SEROQUEL XR

Company: ASTRAZENECA CANADA INC

DIN DIN name Active Ingredient(s) Strength Dosage Form Route of Administration
02300184SEROQUEL XRQUETIAPINE (QUETIAPINE FUMARATE)50 MGTABLET (EXTENDED-RELEASE)ORAL
02321513SEROQUEL XRQUETIAPINE (QUETIAPINE FUMARATE)150 MGTABLET (EXTENDED-RELEASE)ORAL
02300192SEROQUEL XRQUETIAPINE (QUETIAPINE FUMARATE)200 MGTABLET (EXTENDED-RELEASE)ORAL
02300206SEROQUEL XRQUETIAPINE (QUETIAPINE FUMARATE)300 MGTABLET (EXTENDED-RELEASE)ORAL
02300214SEROQUEL XRQUETIAPINE (QUETIAPINE FUMARATE)400 MGTABLET (EXTENDED-RELEASE)ORAL
Search Reported Side Effects Report a Side Effect

Summary Reports

Summary Safety Review - Atypical antipsychotics - Assessing the Potential Risk of Sleep Apnoea
Summary Safety Review - Atypical antipsychotics - Assessing the Potential Risk of Urinary Retention
Summary Safety Review - Atypical Antipsychotics - Liver failure
Summary Safety Review - Atypical antipsychotics - Assessing the potential risk of sleep walking and sleep-related eating disorder
Summary Safety Review - Atypical antipsychotics - Assessing the potential risk of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)

Consumer Information

The Consumer Information is not yet available in the Drug and Health Product Register. Try searching on the active ingredient(s) to find other similar products.

Date modified: